Lung Function Tests Market Research Report - Forecast till 2027

Lung Function Tests Market Information: By Type (Spirometry, Bronchial Provocation Test), Indication (Asthma, Chronic Bronchitis, Respiratory Infections, COPD, Cystic Fibrosis), Devices (Spirometer, Oscillometer), End-User - Forecast Till 2027

ID: MRFR/LS/3401-HCR | | Region: Global | 110 pages

Lung Function Tests Market Overview


Lung function tests, also known as pulmonary function test is used for the diagnosis of lung disorders such as asthma, respiratory infections, chronic obstructive pulmonary disease (COPD), and others. These group of tests also determine the functioning of the lungs, and the ability of a person to breath. They are also a part of tests for routine examination by the healthcare provider. The healthcare provider may recommend lung function tests to diagnose the suspected lung disease, plan the treatment, and decide whether to continue the ongoing treatment or change it and even to stop the treatment if required. Therefore, lung function test plays a vital role in the diagnosis of various respiratory diseases, and lung disorders.


Rising prevalence of lung diseases such as asthma, COPD, and others, availability of lung function test devices, and increasing demand for lung function tests are important factors accelerating the growth of the lung function tests market. Technological advancements in lung testing and the growing geriatric population are also influencing the lung function tests market growth. Changing lifestyle, and smoking addiction are leading to a number of lung problems such as lung cancer, which is further driving the growth of the lung function tests market.


The lung function tests market is expected to grow at a CAGR of 5.7% during the forecast period.


Regional Analysis of the Lung Function Tests Market


America is the leading market for lung function tests owing to the rising prevalence of various types of allergies in the U.S. According to the American College of Allergy Asthma and Immunology, allergic asthma, food allergy, and eczema are the most common types of allergies in the U.S. It further stated that 1 in every 12 people is suffering from allergic rhinitis in the U.S.


Europe is the second-largest market for lung function tests. In Europe, the prevalence of allergic conditions is found to be increasing rapidly. Therefore, the rising prevalence of allergic conditions such as asthma, food allergy, and anaphylaxis is increasing the demand for diagnostic services. Furthermore, rising awareness regarding available treatments and skin testing are fueling the growth of the lung function tests market. As per the European Academy of Allergy and Clinical Immunology, 150 million EU citizens have the chronic allergic diseases. Additionally, 100 million Europeans have allergic rhinitis.


The Asia Pacific market is expected to grow at the fastest pace and is driven by the high prevalence of asthma, rising geriatric population, and increasing environmental population. Weak immune systems and high prevalence of asthma are major risk factors for allergies among the elderly population. Additionally, the prevalence of COPD is also on the rise, which is boosting the growth of the lung function tests market.


The Middle East & Africa also show a steady rise in the lung function tests market owing to the high prevalence of chronic respiratory diseases like asthma, and improving healthcare infrastructure. Increasing demand for diagnostic services also influences the lung function tests market growth in the Middle East & African countries.


FIGURE 1: Lung Function Tests Market by Region, 2016 (%)
Lung Function Tests Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Segments 


The lung function tests market is segmented on the basis of type, indication, devices, and end-user.


On the basis of the type, the lung function tests market is segmented into spirometry, gas diffusion test, body plethysmograph, bronchial provocation test, and others.


On the basis of the indication, the lung function tests market is segmented into asthma, chronic bronchitis, respiratory infections, chronic obstructive pulmonary disease, cystic fibrosis, pneumonia, lung cancer, and others.


On the basis of the devices, the lung function tests market is segmented into a spirometer, breath CO monitor, oscillometer, ergospirometer, dose controlled drug nebulizer, and others.


On the basis of the end-user, the lung function tests market is segmented into hospitals, clinics, diagnostic centers, and others.


Research Methodology Research Methodology


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Key Players in the Lung Function Tests Market


Some of the Key Players in lung function tests market are CareFusion Corporation (U.S.), MGC Diagnostic Corporation (U.S.), General Electric Company (U.S.), Perkin Elmer (U.S), Carestream Health, Inc. (U.S.), COSMED srl (Italy), NIHON KOHDEN CORPORATION (Japan), and others.


Intended Audience



  • Drug Manufacturers

  • Drug Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   5.7% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Indication, Devices
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   CareFusion Corporation (U.S.), MGC Diagnostic Corporation (U.S.), General Electric Company (U.S.), Perkin Elmer (U.S), Carestream Health, Inc. (U.S.), COSMED srl (Italy), NIHON KOHDEN CORPORATION (Japan), and others.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising prevalence of lung diseases
  • Availability of lung function test devices
  • Increasing demand for lung function tests
  • Technological advancements in lung testing
  • Growing geriatric population
  • Changing lifestyle, and smoking addiction